Mark F. Kubik BOSTON and LONDON, May 01, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology...
Oncology
Akari Therapeutics (NASDAQ: AKTX) has appointed Mark F. Kubik as Head of...
